The Home Positive Airway Pressure (HomePAP) study was a multisite, nonblinded, randomized controlled trial that enrolled 373 patients at seven American Academy of Sleep Medicine (AASM)-accredited academic sleep centers with a high pretest probability of moderate to severe OSA (based on a clinical algorithm). Eligible subjects were evaluated in clinic and randomized to one of two management pathways: 1) laboratory-based and 2) home-based. All subjects with an AHI ≥ 15 who underwent a successful CPAP titration study were offered CPAP therapy. Subjects were re-evaluated in clinic after 1- and 3-month follow-up periods.
Read more about HomePAP at ClinicalTrials.gov (NCT00642486).
When using this dataset, please cite the following:
Please include the following text in the Acknowledgements:
The Home Positive Airway Pressure study (HomePAP) was supported by the American Sleep Medicine Foundation 38-PM-07 Grant: Portable Monitoring for the Diagnosis and Management of OSA. The National Sleep Research Resource was supported by the National Heart, Lung, and Blood Institute (R24 HL114473, 75N92019R002).
/datasets (introduction)
Core data from the baseline and follow-up visits.
/polysomnography (introduction)
Overnight home- and lab-based polysomnography (PSG) data from the baseline visit.